Related Experiment Video

Updated: Oct 17, 2025

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

7.7K

AHNAK2 promotes thyroid carcinoma progression by activating the NF-κB pathway

Runyi Ye1, Dongwei Liu2, Hongyu Guan3

  • 1Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

Life Sciences
|October 10, 2021
PubMed

Insights

Thyroid carcinoma metastasis is a key cause of treatment failure. This study reveals AHNAK2 (AHNAK Nucleoprotein 2) promotes thyroid cancer spread by activating the NF-κB pathway, identifying it as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Thyroid carcinoma metastasis significantly impacts treatment outcomes and patient prognosis.
  • Understanding the molecular drivers of thyroid cancer metastasis is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the role of AHNAK Nucleoprotein 2 (AHNAK2) in the metastasis of thyroid carcinoma.
  • To explore the underlying molecular mechanisms by which AHNAK2 influences thyroid cancer progression.

Main Methods:

  • Quantitative analysis of AHNAK2 expression in thyroid carcinoma tissues.
  • In vitro and in vivo experiments involving AHNAK2 knockdown in thyroid cancer cells.
  • Investigation of the nuclear factor kappa B (NF-κB) signaling pathway.

Main Results:

  • AHNAK2 expression was significantly upregulated in thyroid carcinoma tissues, particularly in metastatic cases.
  • High AHNAK2 expression correlated with poor patient prognosis.
  • Knockdown of AHNAK2 suppressed thyroid carcinoma cell migration, invasion, and metastasis.
  • AHNAK2 knockdown led to reduced activity of the NF-κB pathway.

Conclusions:

  • AHNAK2 plays a critical role in promoting thyroid carcinoma metastasis.
  • AHNAK2 facilitates cancer progression through the activation of the NF-κB pathway.
  • AHNAK2 represents a novel and promising therapeutic target for treating metastatic thyroid carcinoma.
Keywords:
AHNAK2MetastasisNF-κB pathwayThyroid carcinoma

More Related Videos

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

9.3K
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.4K

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.8K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.7K